080808 Capital invests along side Pacific Advantage Capital in Flashback Technologies (“FBT”), a medical data analytics platform whose main product is a hemodynamic (flow of blood to bodily organs) monitoring program, which measures cardiovascular stability and helps determine a patient’s intravascular volume status in real time called the Compensatory Reserve Index ("CRI").  On Jaunary 4th, 2017, FBT announced that it had been granted de novo clearance by the FDA to market a device using this algorithmic product.

See www.flashbacktechnologies.com for more.